Mycoses

Article	Citations
	192
Issue Information	143
Immunohistochemical analysis of chronic and recurrent dermatophytosis	134
High attenuation mucus in bronchi with allergic bronchopulmonary mycosis	120
	103
Intra‐ and inter‐laboratory comparison of mDixon and FastFung broths for Malassezia antifungal susceptibility testing	82
	78
Development of single‐tube real‐time PCR assay for the rapid detection of Aspergillus and Fusarium—The two most common causative agents in fungal keratitis	73
Issue Information	54
Issue Information	53
Issue Information	47
Vaginal microbiota in pregnant women with inflammatory rheumatic and inflammatory bowel disease: A matched case‐control study	45
Issue Information	42
Comparison of four diagnostic criteria for invasive pulmonary aspergillosis—A diagnostic accuracy study in critically ill patients	42
	39
Physicians' knowledge of invasive fungal disease in China	39
	38
Seasonality of sporotrichosis in Brazil: A modelled analysis of the epidemic in São Paulo, 2011–2020	35
Author Index	34
In vitro activities of 8 antifungal drugs against 126 clinical and environmental Exophiala isolates	32
Issue Information	31
Clinical characteristics and risk factors for late‐onset pneumocystis jirovecii pneumonia in kidney transplantation recipients	30
Clonal spread of fluconazole‐resistant C. parapsilosis in patients admitted to a referral hospital located in Burgos, Spain, during the COVID‐19 pandemic	29
Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study	29
Review Article White Piedra: Review of 131 cases	29

Mucocutaneous mycoses in people living with human immunodeficiency virus in Indonesia	27
Therapeutic drug monitoring of posaconazole delayed release tablet while managing COVID‐19–associated mucormycosis in a real‐life setting	27
Identification of distinct immunophenotypes in chronic pulmonary aspergillosis using cluster analysis	27
Issue Information	25
Cover image	25
A contemporary investigation of burden and natural history of aspergillosis in people living with HIV/AIDS	25
	25
	25
Novel cases of cutaneous phaeohyphomycosis by Alternaria alstromeriae, Epicoccum tritici and Phialemonium obovatum from North India	23
COVID‐19‐associated subacute invasive pulmonary aspergillosis	23
NLRP3 regulates CIITA/MHC II axis and interferon‐γ‐inducible chemokines in Malassezia globosa‐infected keratinocytes	23
Secondary invasive fungal infection in hospitalised patients with COVID‐19 in the United States	22
In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates	22
Exome Sequencing of a Blastomycosis Case–Control Cohort From Manitoba and Northwestern Ontario, Canada	22
Comparative evaluation of host immune response and cytokine signature pertaining to Th1 and Th2 immune arms in serum and tissue among patients of acute localised vs. chronic disseminated de	21
In Vitro activity of ravuconazole against Candida auris and vaginal candida isolates	21
	20
	20
Issue Information	20
Global Insights and Trends in Research on Dermatophytes and Dermatophytosis: A Bibliometric Analysis	19
Issue Information	19
Sporothrix and Sporotrichosis: A South African Perspective on a Growing Global Health Threat	19
Intra‐Abdominal Candidiasis in Cancer Patients: A 10‐Year Experience in a Middle‐Income Country	19
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta‐analysis	18
Epidemiological analysis of nail aspergillosis and non‐dermatophyte moulds. Criteria for the involvement of Aspergillus in 102 cases of onychomycosis at Montpellier University Hospital, France	18
Cover Image	17
Exploring the clinical features and risk factors for children tinea capitis complicated with allergic diseases	17
Reimbursement of innovative pharmaceuticals in English and Spanish hospitals—The example of isavuconazole	17
Is there still a place for serum galactomannan in the diagnosis of invasive aspergillosis in children at high risk and under antifungal prophylaxis?	17
Low toxicity contributes to Sporothrix globosa invade the skin of patients in low‐epidemic areas of China	17
Systematic review of neuroparacoccidioidomycosis: The contribution of neuroimaging	17
A thermal adaptation landscape related to virulence in Mucor irregularis transcriptional profiles	16
First detection of triazole‐resistant aspergillus fumigatus harbouring the TR34/L98H Cyp51A mutation in Burkina Faso	16
Identification of primary metabolites in fungal species of Trichophyton mentagrophyte and Trichophyton rubrum by NMR spectroscopy	16
South Asian (Clade I) Candida auris meningitis in a paediatric patient in Iran with a review of the literature	16
The use of combined PCR, fluorescence in situ hybridisation and immunohistochemical staining to diagnose mucormycosis from formalin‐fixed paraffin‐embedded tissues	16
Genetic differences between Japan and other countries in cyp51A polymorphisms of Aspergillus fumigatus	16
Coccidioidomycosis in Oklahoma: A retrospective case series	15
Adhesive and biofilm‐forming Candida glabrata Lebanese hospital isolates harbour mutations in subtelomeric silencers and adhesins	15
Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA)	15
Candida albicans skin infection in diabetic patients: An updated review of pathogenesis and management	15
	15
Retrospective Epidemiology of Dermatomycosis in Kinshasa, Democratic Republic of Congo, From 2000 to 2023	15
Cryptococcosis in the Democratic Republic of Congo from 1953 to 2021: A systematic review and meta‐analysis	15
State of Medical Mycology at German Academic Medical Centres: A Survey of the German‐Speaking Mycological Society (DMYKG) and the Paul‐Ehrlich‐Society for Chemotherapy (PEG)	14
Emergence of Candida auris in intensive care units in Algeria	14
Evaluation of the CHROMagar Candida Plus medium for presumptive identification of yeasts and MALDI‐TOF MS identification	14
Multicenter Candida auris outbreak caused by azole‐susceptible clade IV in Pernambuco, Brazil	14
Therapeutic efficacy of topically used luliconazole vs. terbinafine 1% creams	14
Endemic mycoses: Expansion of traditional geographic ranges and pitfalls in management	14

COVID‐19‐associated aspergillosis in a Brazilian referral centre: Diagnosis, risk factors and outcomes	14
Non‐dermatophyte fungi in onychomycosis—Epidemiology and consequences for clinical practice	14
Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non‐fumigatus): A multicentre, non‐interventional regist	13
Global prevalence of onychomycosis in general and special populations: An updated perspective	13
Prevalence of chronic pulmonary aspergillosis regarding time of tuberculosis diagnosis in Brazil	13
Improved effectiveness of an increased dose of griseofulvin for treating Tinea capitis among refugee children in Israel: A retrospective cohort study	13
Clinical characteristics and outcomes of invasive and non‐invasive fusariosis in South Korea	13
Risk factors for pulmonary mucormycosis in subjects with diabetes mellitus—A case‐control study	13
Microbiological culture combined with PCR for the diagnosis of onychomycosis: Descriptive analysis of 121 patients	13
T‐cell dysfunction as a potential contributing factor in post‐COVID‐19 mucormycosis	12
Patients with recurrent vulvovaginal candidiasis exhibit a decrease in both the fungicidal activity of neutrophils and the proliferation of peripheral blood mononuclear cells	12
A longitudinal study on fluconazole resistance in Candida albicans vaginal isolates	12
Mucormycosis and COVID‐19: An epidemic within a pandemic in India	12
The double‐edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza‐associated mucormycosis versus COVID‐19 associated mucormycosis	12
Report of terbinafine resistantTrichophytonspp. in Italy: Clinical presentations, molecular identification, antifungal susceptibility testing and mutations in the squalene epoxidase gene	12
Global epidemiological burden of fungal infections in cirrhosis patients: A systematic review with meta‐analysis	12
Changing demographics and risk factors for cryptococcosis: A 12‐year review at a tertiary care centre	12
The influence of CYP2C19 polymorphisms on voriconazole trough concentrations: Systematic review and meta‐analysis	11
Updated estimation of the burden of fungal disease in Vietnam	11
A review of significance of Aspergillus detection in airways of ICU COVID‐19 patients	11
Usefulness of 18F‐FDG PET‐CT for the management of invasive fungal infections: A retrospective cohort from a tertiary university hospital	11
Saksenaea vasiformis infection: Extensive abdominal wall necrotizing fasciitis with systematic review and analysis of 65 cases	11
Increased incidence of rhino‐orbital mucormycosis in an educational therapeutic hospital during the COVID‐19 pandemic in western Iran: An observational study	11
Pneumocystis jirovecii pneumonia in patients with previously untreated acute myeloid leukaemia	11
Diverse Colonisation and Disease Associations of the Human Commensal Malassezia: Our Body's Secret Tenant	10
Diagnostic values of ten  methods in patients with onychomycosis: A network meta‐analysis	10
Let's talk about sex characteristics—As a risk factor for invasive fungal diseases	10
Surgical management of chronic pulmonary aspergillosis in Africa: A systematic review of 891 cases	10
Multi‐state evaluation of Candida infections in burn patients	10
Performance of the IMMY® sona Aspergillus lateral flow assay for the detection of galactomannan in tracheal aspirate samples from Brazilian patients with COVID‐19‐associat	10
Update of the Epidemiology of the Sporotrichosis Epidemic in the state of Rio Grande do Sul, Brazil	10
	10
Paediatric cutaneous mucormycosis: A case report and review of the literature	10
Molecular Epidemiology and Antifungal Susceptibility Profile of Candidozyma Isolates From Argentina	10
A retrospective Italian analysis on the characteristics of invasive fungal infections in the intensive care unit setting: CHARTER‐IFI study	10
Inter‐observer reliability of the Onychomycosis Severity Index depending on clinical experience: A review of 50 cases	10
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole	10
Author Index	9
Mechanism of azole resistance in Candida vulturna, an emerging multidrug resistant pathogen related with Candida haeumulonii and Candida auris	9
Rhinosporidiosis—Factors predicting disease recurrence	9
Abstracts	9
Activity of amorolfine or ciclopirox in combination with terbinafine against pathogenic fungi in onychomycosis—Results of an in vitro investigation	9
Issue Information	9
‘CT and CT image‐based texture image analysis in radiological diagnostics of allergic fungal rhinosinusitis’	9
Antifungal activity of aminopyrrolnitrin against Trichophyton verrucosum in a guinea pig model of dermatophytosis	9
In vitro activities of 8 antifungal agents against geophilic dermatophyte isolates	9
Acitretin: Could it be a new therapeutic player in the field of onychomycosis?	9
Issue Information	8
Topical sertaconazole during pregnancy and risk of adverse pregnancy outcome and major congenital anomalies: Comparative study in the EFEMERIS database	8
Pan‐azole‐resistant Meyerozyma guilliermondii clonal isolates harbouring a double F126L and L505F mutation in Erg11	8
Effect of coccidioidomycosis prophylaxis in selecting non‐Candida albicans species amongst solid organ transplant recipients in Arizona	8
Issue Information	8
	8
Using (1,3)‐β‐D‐glucan concentrations in serum to monitor the response of azole therapy in patients with eumycetoma caused by Madurella mycetomatis	8
Responses of keratinocytes to Trichophyton mentagrophyte infection based on whole transcriptome analysis	8
Combination therapy with itraconazole and terbinafine for phaeohyphomycosis caused by Exophiala spinifera: A case report and literature review	8
Effect of the implementation of clinical guidelines on management of candidemia in elderly patients	8
Issue Information	8
Prognostic factors for mycological cure in patients with onychomycosis caused by Neoscytalidium dimidiatum: A retrospective cohort study	8
Issue Information	8
Epidemiology of dermatomycoses and onychomycoses in Ireland (2001–2020): A single‐institution review	8
Concomitant use of isavuconazole and CYP3A4/5 inducers: Where pharmacogenetics meets pharmacokinetics	7
Cover Image	7
The role of oxidative stress in onychomycosis: Thiol/disulphide homeostasis	7
	7
Exploring the intersection of Aspergillus fumigatus biofilms, infections, immune response and antifungal resistance	7
Issue Information	7
Author Index	7
	7
Green natural nail polish modified with essential oils to treat onychomycosis	7
Multilocus sequence typing (MLST) analysis reveals many novel genotypes and a high level of genetic diversity in Candida tropicalis isolates from Italy and Africa	7
Differential lipase virulence in Malassezia furfur dimorphism isolated from pityriasis versicolor patients and healthy individuals	7
Issue Information	7
Issue Information	7
	7
Majocchi's granuloma: Autoinoculation and adaption of Trichophyton rubrum with molecular evidence	7
Temporal trends in antifungal susceptibility of Cryptococcus neoformans isolates from a reference laboratory in the United States, 2011–2021	6
Incidence, risk factors and mortality of invasive pulmonary aspergillosis in patients with influenza: A systematic review and meta‐analysis	6
Prototype early diagnostic model for invasive pulmonary aspergillosis based on deep learning and big data training	6
Distribution of Aspergillus species and prevalence of azole resistance in clinical and environmental samples from a Spanish hospital during a three‐year study period	6

Baseline chest computed tomography for diagnosis of invasive aspergillosis in patients with acute myeloid leukaemia treated with intensive chemotherapy: A retrospective single‐centre cohort study	6
Machine‐learning‐based virtual screening to repurpose drugs for treatment of Candida albicans infection	6
Serious fungal disease incidence and prevalence in Indonesia	6
Voriconazole is superior to combined itraconazole/isotretinoin therapy and itraconazole monotherapy in recalcitrant dermatophytosis	6
Characterisation of the nail microbiome in psoriatic and nonpsoriatic patients with onychomycosis	6
Drug repurposing against Candida auris: A systematic review	6
PTX3 gene polymorphism associated with cryptococcosis in HIV‐uninfected Chinese patients	6
The clinical significance of Aspergillus‐positive respiratory samples	6
The prognostic factors for cryptococcal meningitis in non‐human immunodeficiency virus patients: An observational study using nationwide database	6
Tinea faciei clinical characteristics, causative agents, treatments and outcomes; a retrospective study in Thailand	6
Issue Information	6
The sphingolipid inhibitor myriocin increases Candida auris susceptibility to amphotericin B	6
Children onychomycosis, a neglected dermatophytosis: A retrospective study of epidemiology and treatment	6
Epidemiology of dermatomycoses in children in Northern Mato Grosso 2015‐2020	6
Cover Image	6
Comparison of dermoscopic characteristics on toenail onychomycosis in psoriatic and non‐psoriatic patients: A prospective study	6
Factors influencing outcomes in candidemia: A retrospective study of patients in a Swedish county	6
A survey of 701 cases of tinea faciei in Hangzhou, southeastern China, from 2018 to 2023	6
Mucormycosis in Africa: Epidemiology, diagnosis and treatment outcomes	6
Species distribution, azole resistance and related molecular mechanisms in invasive Candida parapsilosis complex isolates: Increase in fluconazole resistance in 21 years	6
Incidence and mortality of COVID‐19‐associated pulmonary aspergillosis: A systematic review and meta‐analysis	5
A screening study for COVID‐19‐associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic	5
Risk Factors and Prognostic Effects of Aspergillosis as a Complication of Nontuberculous Mycobacterial Pulmonary Disease: A Nested Case–Control Study	5
Inopinatus corneliae sp. nov. gen. nov. isolated from human skin: A newly discovered keratinophilic hyphomycete, order Onygenales	5
Issue Information	5
Active screening of COVID‐19‐associated pulmonary aspergillosis with serum beta‐glucan and endotracheal aspirates galactomannan and fungal culture	5
Diagnosis of fungal opportunistic infections in people living with HIV from Guatemala and El Salvador	5
Effects of oestrogen on vulvovaginal candidosis	5
Serologic biomarkers in Candida and Aspergillus infections of the central nervous system: A comparison of galactomannan, mannan and β‐1,3‐D‐gucan testing from serum and cerebr	5
Analysis of 15 cases from a monocentric cohort of 307 liver abscesses	5
Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study)	5
Disease burden and demographic characteristics of mucormycosis: A nationwide population‐based study in Taiwan, 2006–2017	5
Incidence of Saccharomyces cerevisiae fungemia in hospitalised patients administered Saccharomyces boulardii probiotic	5
Evaluation of Eazyplex® LAMP test for fast Candida auris direct detection of colonized patients	5
Serum iron indices in COVID‐19‐associated mucormycosis: A case–control study	5
Global, regional, and national burden of fungal skin diseases in 204 countries and territories from 1990 to 2021: An analysis of the global burden of disease study 2021	5
Epidemiological changes of invasive fungal disease in children with cancer: Prospective study of the National Child Program of Antineoplastic Drugs network, Chile	5
Inter‐Institutional Dynamics and Impact of Fluconazole‐Resistant Candida parapsilosis	5
Optimization of a commercial Histoplasma galactomannan EIA test in a population from an endemic area of histoplasmosis in southern Brazil	5
Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k)	5
Risk factors and outcomes of deep tissue Candida invasion in neonates with invasive candidiasis	5
Axillary Digital Thermometers uplifted a multidrug‐susceptible Candidaauris outbreak among COVID‐19 patients in Brazil	5
Invasive aspergillosis due to Aspergillus cryptic species: A prospective multicentre study	5
As the virus sowed, the fungus reaped! A comparative analysis of the clinico‐epidemiological characteristics of rhino‐orbital mucormycosis before and during COVID‐19 pandemic	5
Prevalence, risk factors, treatment and outcome of multidrug resistance Candida auris infections in Coronavirus disease (COVID‐19) patients: A systematic review	5
COVID‐19–associated pulmonary aspergillosis: a prospective single‐center dual case series	5
Antifungal use via outpatient parenteral antimicrobial therapy	5
Imported Systemic Endemic Mycoses in Spain 1997–2021: An Analysis of a National Hospital Database	5
Ex Vivo Fungal Nail Penetration Study: Effects of Causative Organisms, Nail Polish and Age	5
Incidence and risk factors for coronavirus disease 2019‐associated pulmonary aspergillosis using administrative claims data	5
Antifungal Resistance Patterns of Microsporum canis: A 27‐Year MIC Study in Mainland China	5
Role of flexible bronchoscopy in the diagnosis of invasive fungal infections	5
Characteristics of candidemia in COVID‐19 patients; increased incidence, earlier occurrence and higher mortality rates compared to non‐COVID‐19 patients	5
Invasive fungal infections in acute and chronic liver impairment: A systematic review	5
Implementation of rapid diagnostics assays for detection of histoplasmosis and cryptococcosis in central american people living with HIV	5
A multicentre external quality assessment: A first step to standardise PCR protocols for the diagnosis of histoplasmosis and coccidioidomycosis	5
Time and cost‐efficient identification of Trichophyton indotineae	5
Efficacy of Amorolfine in Onychomycosis Treatment: A Mixed‐Effects Models and Multivariate Logistic Regression Analysis	5
Issue Information	4
	4
Issue Information	4
Prevalence, genetic diversity and antifungal susceptibility profiles of F. fujikuroi, F. solani and Fusarium incarnatum‐equiseti species complexes from onychomycosis in north of I	4
Medium‐chain fatty acid esters are effective even in azole‐resistant Malassezia pachydermatis	4
Specific microRNA/mRNA expression profiles and novel immune regulation mechanisms are induced in THP‐1 macrophages by in vitro exposure to Trichosporon asahii	4
How does temperature trigger biofilm adhesion and growth in Candida albicans and two non‐Candida albicans Candida species?	4
Issue Information	4
Performance of the RealStar®Pneumocystis jirovecii PCR kit for the diagnosis of Pneumocystis pneumonia	4
Aetiological changes of tinea capitis in the Hubei area in 60 years: Focus on adult tinea capitis	4
Diagnostic performance of noncultural methods for central nervous system aspergillosis	4
Issue Information	4
	4
	4
Propensity of Candida spp. prosthetic joint infection clinical isolates to form aggregates in synovial fluid and the clinical ramifications	4
Issue Information	4
Immune and metabolic perturbations in COVID‐19‐associated pulmonary mucormycosis: A transcriptome analysis of innate immune cells	4
Modified Pitt bacteremia score for predicting mortality in patients with candidaemia: A multicentre seven‐year retrospective study conducted in Japan	4
Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Pr	4
Estimated burden of serious fungal infections in Togo	4
Effect of glucocorticoids on the development of COVID‐19‐associated pulmonary aspergillosis: A meta‐analysis of 21 studies and 5174 patients	4
Epidemiology of aspergillosis in hospitalised Spanish patients—A 21‐year retrospective study	4
Exploring treatment and antifungal resistance in an outbreak of tinea caused by Microsporum audouinii	4
Histoplasma capsulatum modulates the immune response, affects proliferation and differentiation, and induces apoptosis of mesenchymal stromal cells	4
CARD9 mutations in patients with fungal infections: An update from the last 5 years	4
Increasing incidence of Trichophyton tonsurans in Munich—A single‐centre observation	4
Quality of life in women with chronic recurrent vulvovaginal candidosis: A sub‐analysis of the prospective multicentre phase IIb/III Prof‐001 study	4
Incidence of invasive fungal diseases in inflammatory bowel disease patients: A nationwide study in South Korea	4
Diagnostic performance of real‐time polymerase chain reaction assay on blood for invasive aspergillosis and mucormycosis	4
Factors responsible for difficult to treat superficial fungal infections: A study from a tertiary healthcare centre in India	4
A simple high‐volume culture technique—Good substitute for polymerase chain reaction for the detection of Aspergillus species in bronchoalveolar lavage samples	4
Tinea pedis in underrepresented groups: All of Us database analysis	3
First case of Rhinocladiella mackenziei brain abscess in Turkey: Case report and review of the literature	3
An open‐label non‐inferiority randomised control trial comparing nebulised amphotericin B with oral itraconazole in patients with pulmonary aspergilloma	3
Aspergillus‐PCR in bronchoalveolar lavage ‐ diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients	3
Compulsory notification of paracoccidioidomycosis: A 14‐year retrospective study of the disease in the state of Paraná, Brazil	3
Molecular identification and antifungal susceptibility profiles of Candida dubliniensis and Candida africana isolated from vulvovaginal candidiasis: A single‐centre experience in Iran	3